These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8601097)

  • 1. Long term adjuvant therapy for primary breast cancer.
    Bulbrook RD
    BMJ; 1996 Feb; 312(7028):389-90. PubMed ID: 8601097
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
    Pritchard KI
    J Clin Oncol; 2005 Aug; 23(22):4850-2. PubMed ID: 16009956
    [No Abstract]   [Full Text] [Related]  

  • 3. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant tamoxifen: how long before we know how long?
    Rea D; Poole C; Gray R
    BMJ; 1998 May; 316(7143):1518-9. PubMed ID: 9582148
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of tamoxifen as treatment of breast cancer.
    Powles TJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should adjuvant chemotherapy be used in elderly women (> or = 70 years) with breast cancer? Contra.
    Di Costanzo F; Gasperoni S; Di Costanzo F
    Tumori; 2002; 88(1 Suppl 1):S91-2. PubMed ID: 11989939
    [No Abstract]   [Full Text] [Related]  

  • 8. LHRH-agonist versus chemotherapy in premenopausal breast cancer?
    Klijn JG
    Eur J Cancer; 2002 Nov; 38 Suppl 6():S45-6. PubMed ID: 12409071
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 2002 Oct; 94(19):1504. PubMed ID: 12359860
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Zammit C; Yelland A; Deutsch G
    Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
    Grana G
    J Surg Oncol; 2006 Jun; 93(7):585-92. PubMed ID: 16705732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
    Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?
    Bramwell VH; Pritchard KI
    Eur J Cancer; 1999 Nov; 35(12):1625-7. PubMed ID: 10674005
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumoristatic action of tamoxifen: experimental evidence for clinical application in stage I and II breast cancer.
    Jordan VC
    J Chemother; 1989 Jul; 1(4 Suppl):1144-7. PubMed ID: 16312810
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer (non-metastatic).
    Dixon JM; Rodger A; Stebbing J
    Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in adjuvant hormonal therapy for postmenopausal women.
    Strasser-Weippl K; Goss PE
    J Clin Oncol; 2005 Mar; 23(8):1751-9. PubMed ID: 15755983
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT).
    Dunn BK; Ford LG
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S49-50. PubMed ID: 11056316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.